FDA Awards Wyss Institute $5.6M for Organs-on-Chips Technology in Assessing Radiation Sickness Countermeasures | GenomeWeb

NEW YORK (GenomeWeb News) – The US Food and Drug Administration announced on Monday that it has awarded Harvard University's Wyss Institute for Biologically Inspired Engineering a $5.6 million contract to assess medical countermeasures for treating radiation sickness using Wyss' organs-on-chips technology.

In work carried out as part of the award, researchers at Wyss will develop models of radiation damage in lung, gut, and bone marrow organs-on-chips and then test possible medical countermeasures for radiation sickness on the models.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: system to track intron gains and losses, role of RUNX during mitosis, and more.

French officials release a report and move to strength safety measures for clinical trials, ScienceInsider reports.

Researchers find different molecular signatures in cancers from men as compared to those from women, the Wall Street Journal reports.

Researchers trace the deaths of a pair of newborn siblings to a mutation in their LIPT1 genes through whole-exome sequencing, Stat News reports.